Same Indication

Pembrolizumab vs Telotristat Etiprate

Pembrolizumab vs Telotristat Etiprate: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Telotristat Etiprate.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days.

Chemical Properties

Type: Pembrolizumab — Antibody; Telotristat Etiprate — Small molecule.